288 related articles for article (PubMed ID: 16314835)
21. Lung tumor-associated dendritic cell-derived amphiregulin increased cancer progression.
Hsu YL; Huang MS; Cheng DE; Hung JY; Yang CJ; Chou SH; Kuo PL
J Immunol; 2011 Aug; 187(4):1733-44. PubMed ID: 21742971
[TBL] [Abstract][Full Text] [Related]
22. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
23. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
24. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis.
Lu X; Wang Q; Hu G; Van Poznak C; Fleisher M; Reiss M; Massagué J; Kang Y
Genes Dev; 2009 Aug; 23(16):1882-94. PubMed ID: 19608765
[TBL] [Abstract][Full Text] [Related]
25. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.
Yasumoto K; Yamada T; Kawashima A; Wang W; Li Q; Donev IS; Tacheuchi S; Mouri H; Yamashita K; Ohtsubo K; Yano S
Clin Cancer Res; 2011 Jun; 17(11):3619-30. PubMed ID: 21482691
[TBL] [Abstract][Full Text] [Related]
26. Membrane type 1-matrix metalloproteinase cleaves off the NH2-terminal portion of heparin-binding epidermal growth factor and converts it into a heparin-independent growth factor.
Koshikawa N; Mizushima H; Minegishi T; Iwamoto R; Mekada E; Seiki M
Cancer Res; 2010 Jul; 70(14):6093-103. PubMed ID: 20587521
[TBL] [Abstract][Full Text] [Related]
27. Caffeoyl pyrrolidine derivative LY52 inhibits tumor invasion and metastasis via suppression of matrix metalloproteinase activity.
Qu X; Yuan Y; Xu W; Chen M; Cui S; Meng H; Li Y; Makuuchi M; Nakata M; Tang W
Anticancer Res; 2006; 26(5A):3573-8. PubMed ID: 17094485
[TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor receptor signaling in hepatocellular carcinoma: inflammatory activation and a new intracellular regulatory mechanism.
Berasain C; Nicou A; Garcia-Irigoyen O; Latasa MU; Urtasun R; Elizalde M; Salis F; Perugorría MJ; Prieto J; Recio JA; Corrales FJ; Avila MA
Dig Dis; 2012; 30(5):524-31. PubMed ID: 23108309
[TBL] [Abstract][Full Text] [Related]
29. ADAMTS-1 metalloproteinase promotes tumor development through the induction of a stromal reaction in vivo.
Rocks N; Paulissen G; Quesada-Calvo F; Munaut C; Gonzalez ML; Gueders M; Hacha J; Gilles C; Foidart JM; Noel A; Cataldo DD
Cancer Res; 2008 Nov; 68(22):9541-50. PubMed ID: 19010931
[TBL] [Abstract][Full Text] [Related]
30. Lung cancer-derived galectin-1 enhances tumorigenic potentiation of tumor-associated dendritic cells by expressing heparin-binding EGF-like growth factor.
Kuo PL; Huang MS; Cheng DE; Hung JY; Yang CJ; Chou SH
J Biol Chem; 2012 Mar; 287(13):9753-9764. PubMed ID: 22291012
[TBL] [Abstract][Full Text] [Related]
31. Wound-induced ATP release and EGF receptor activation in epithelial cells.
Yin J; Xu K; Zhang J; Kumar A; Yu FS
J Cell Sci; 2007 Mar; 120(Pt 5):815-25. PubMed ID: 17284517
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.
Kivisaari AK; Kallajoki M; Ala-aho R; McGrath JA; Bauer JW; Königová R; Medvecz M; Beckert W; Grénman R; Kähäri VM
Br J Dermatol; 2010 Oct; 163(4):726-35. PubMed ID: 20586780
[TBL] [Abstract][Full Text] [Related]
33. Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer.
Narita K; Chien J; Mullany SA; Staub J; Qian X; Lingle WL; Shridhar V
J Biol Chem; 2007 May; 282(19):14413-20. PubMed ID: 17363371
[TBL] [Abstract][Full Text] [Related]
34. Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis.
El Hour M; Moncada-Pazos A; Blacher S; Masset A; Cal S; Berndt S; Detilleux J; Host L; Obaya AJ; Maillard C; Foidart JM; Ectors F; Noel A; Lopez-Otin C
Oncogene; 2010 May; 29(20):3025-32. PubMed ID: 20208563
[TBL] [Abstract][Full Text] [Related]
35. Enhanced effect of epidermal growth factor on pulmonary metastasis and in vitro invasion of rat mammary carcinoma cells.
Hamada J; Nagayasu H; Takayama M; Kawano T; Hosokawa M; Takeichi N
Cancer Lett; 1995 Mar; 89(2):161-7. PubMed ID: 7889524
[TBL] [Abstract][Full Text] [Related]
36. Heparan sulfate is essential to amphiregulin-induced mitogenic signaling by the epidermal growth factor receptor.
Johnson GR; Wong L
J Biol Chem; 1994 Oct; 269(43):27149-54. PubMed ID: 7929459
[TBL] [Abstract][Full Text] [Related]
37. Carp oil or oleic acid, but not linoleic acid or linolenic acid, inhibits tumor growth and metastasis in Lewis lung carcinoma-bearing mice.
Kimura Y
J Nutr; 2002 Jul; 132(7):2069-75. PubMed ID: 12097695
[TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor mediates detachment from and invasion through collagen I and Matrigel in Capan-1 pancreatic cancer cells.
Shirk AJ; Kuver R
BMC Gastroenterol; 2005 Mar; 5():12. PubMed ID: 15801978
[TBL] [Abstract][Full Text] [Related]
39. Expression of the epidermal growth factor system in human middle ear cholesteatoma.
Thorup MB; Munk M; Poulsen SS; Gaihede M; Nexo E; Sorensen BS; Ovesen T
Acta Otolaryngol; 2014 Feb; 134(2):124-34. PubMed ID: 24256036
[TBL] [Abstract][Full Text] [Related]
40. Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis.
Oshima H; Popivanova BK; Oguma K; Kong D; Ishikawa TO; Oshima M
Cancer Sci; 2011 Apr; 102(4):713-9. PubMed ID: 21205091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
